Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Recruiting 3Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 3NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Thoracic 1Gynecologic 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pembrolizumab 131Carboplatin 106Paclitaxel 66Cisplatin 61Gemcitabine 57Pemetrexed 56Bevacizumab 50Docetaxel 47Fluorouracil 40Oxaliplatin 38Dexamethasone 34130-nm albumin-bound paclitaxel 34Leucovorin 33atezolizumab 32Cetuximab 32durvalumab 30Nivolumab 28Rituximab 26Cyclophosphamide 26Capecitabine 26Prednisone 25Fulvestrant 24enzalutamide 23Lenalidomide 22venetoclax 21Letrozole 20Irinotecan 20Doxorubicin 17ribociclib 16pomalidomide 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Vinorelbine × 30 days × Clear all
NCT07007559 2026-06-05

ASPEN-09-03

ALX Oncology Inc.

Phase 2 Recruiting
120 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06875128 2026-06-01

DELUMA

Delcath Systems Inc.

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
686 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07461454 2026-05-26

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

MediLink Therapeutics (Suzhou) Co., Ltd.

Phase 3 Recruiting
376 enrolled
Breast

Breast Neoplasms

NCT06564844 2026-05-22

TROPION-Lung12

AstraZeneca

Phase 3 Active not recruiting
25 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡